China Reliable Steroid Powder Supplier - Dewael Biotech
EnglishالعربيةNederlandsFrançaisDeutschΕλληνικάहिन्दी; हिंदीItalianoPolskiPortuguêsРусскийEspañolภาษาไทยTürkçeУкраїнська

Sarm Raw Powders

» Sarm Raw Powders

  • Specifications

 

MK-1775 Powder (955365-80-7)

 

Product Name: MK-1775
CAS: 955365-80-7
MF: C27H32N8O2
MW: 500.59538
Assay: 99%
Grade: Pharmaceutical Grade
Apperance: Yellow powder
Usage: only for lab research.

 

MK-1775 Description:

 

MK 1775 abolishes cyclin-dependent kinase 1 (CDC2) activity by phosphorylation of the Tyr15 residue. It abrogates a DNA damage checkpoint (G2-phase), leading to apoptosis in combination with several DNA-damaging agents selectively in p53-deficient tumor cell lines. It is under clinical trial for advanced solid tumors.

 

MK-1775 Application:

 

MK-1775 treatment led to the inhibition of Wee1 kinase and reduced inhibitory phosphorylation of its substrate Cdc2. MK-1775, when dosed with gemcitabine, abrogated the checkpoint arrest to promote mitotic entry and facilitated tumor cell death as compared to control and gemcitabine treated tumors. MK-1775 monotherapy did not induce tumor regressions. However, the combination of gemcitabine with MK-1775 produced robust anti-tumor activity and remarkably enhanced tumor regression response (4.01 fold) compared to gemcitabine treatment in p53-deficient tumors. Tumor re-growth curves plotted after the drug treatment period suggest that the effect of the combination therapy is longer-lasting than that of gemcitabine. None of the agents produced tumor regressions in p53-wild type xenografts.

MK-1775 inhibits Wee1 kinase in an ATP-competitive manner. Compared to Wee1, MK-1775 displays 2- to 3-fold less potency against Yes with IC50 of 14 nM, 10-fold less potency against seven other kinases with >80% inhibition at 1 μM, and >100-fold selectivity over human Myt 1, another kinase that inhibits cyclin-dependent kinase 1 (CDC2) by phosphorylation at an alternative site (Thr14).

By abrogating the DNA damage checkpoint via blockade of Wee1 activity in WiDr cells bearing mutated p53, MK-1775 treatment inhibits the basal phosphorylation of CDC2 at Tyr15 (CDC2Y15) with EC50 of 49 nM, and suppresses gemcitabine-, carboplatin- or cisplatin-induced phosphorylation of CDC2 and cell cycle arrest in a dose-dependent manner, with EC50 of 82 nM and 81 nM, 180 nM and 163 nM, as well as 159 nM and 160 nM, respectively. MK-1775 treatment alone at 30-100 nM has no significant antiproliferative effect in WiDr and H1299 cells, whereas MK-1775 at 300 nM, sufficient to inhibit Wee1 by >80%, displays moderate but significant antiproliferative effects by 34.1% in WiDr cells and 28.4% in H1299 cells.

Share With Friends

Enquiry Form ( we will get back you as soon as possible )

Name:
*
Email:
*
Message:

Verification:
0 + 3 = ?

Maybe you like also

  • Product Categories

  • Share With Friends

  • Customer Reviews

    Customer Service was excellent , very fast shipping! Very pleased with this company and their products! Thanks

    — Mr. Mack

     

    best supplier i’ve met, always high purity with smart packing

    — Mr.Steve

     

    super! spend more than 6 orders, quality products, fast delivery, perfect communication, perfect team I recommend thank you

    — Mr. Luis

     

    Great company to deal with.High quality products.
    Yes it did come thru in Australia. No problems. Will deal with dewael again for sure. Thanks so much.
    — Mr. Jeff

     

    I have ordered testo that is of good quality and cheap price. Fast delivery of products without problems. Very good customer serve, they are mi best friends and the factory is the TOP. Reccomndable.

    —John

  • Contact Us

    URL:www.steroid-sarms.com

    Email:Rowe@steroid-sarms.com

    Cerina@steroid-sarms.com

    Address:North Baiyun Ave.,Baiyun,Guangzhou,China

  • BTC LIVE PRICES